Syndax Pharmaceuticals (SNDX) – Trading Halts
-
Syndax Pharmaceuticals (SNDX) to Resume Trading at 5:05 pm
-
Syndax Pharmaceuticals (SNDX) Phase 3 E2112 Trial of Entinostat Plus Exemestane in Patients with HR+, HER2- Breast Cancer Did Not Achieve Primary Endpoint
-
Back to SNDX Stock Lookup